Clinical Trials Browser

Phase 3 × Genetic Predisposition to Disease × Docetaxel × Clear all

NCT03359694 2017-12-02

Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer

Phase 3 Unknown

Breast Neoplasms, Genetic Predisposition to Disease